Dexcom Class Action Over Sales Force Issues Partially Tossed

Dexcom Inc. partially won its bid to toss proposed class action claims alleging the health-care technology company misled investors about the ability of its sales force to hit ambitious revenue growth goals.

Judge Robert S. Huie in the US District Court for the Southern District of California dismissed the bulk of claims against Dexcom in a Tuesday order. The two surviving claims, alleging fraudulent misrepresentations, both related to Dexcom’s assurances that it was “taking share” of the market for glucose monitors used by Type 2 diabetes patients taking basal insulin.

The glucose monitor manufacturer had a relatively small sales force ...